Stockwinners Market Radar for August 18, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

HNHPF...

Hot Stocks

20:06 EDT Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Churchill Capital Corp VII (CVII), a publicly-traded special purpose acquisition company, and CorpAcq Holdings, a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, announced that they have mutually agreed to terminate their previously announced merger agreement due to IPO market conditions, effective today. 2. Foxconn's (HNHPF) chairman on Saturday defended its hiring practices after New Delhi ordered investigations following a Reuters report that the Apple (AAPL) supplier rejects married women from iPhone assembly jobs, Reuters' Praveen Paramasivam reports. "Foxconn hires regardless of gender, but women make up a big part of our workforce here," Young Liu said during the opening ceremony for a hostel complex for its workers near Chennai in the southern Indian state of Tamil Nadu. "I emphasize married women greatly contribute to the efforts of what we're doing here," he added, making his first comments since the Reuters investigation. The Reuters investigation published in June found that Foxconn systematically excluded married women from jobs at its main India iPhone assembly plant on the grounds they have more family responsibilities than their unmarried counterparts. 3. Shares of Medtronic (MDT), at a recent $81.74, are down slightly this year as investors express concerns that weight-loss drugs may reduce demand for some Medtronic's diabetes and cardiovascular products, as well as equipment the company makes for bariatric weight loss surgical procedures for obese patients, Paul R. La Monica writes in this week's edition of Barron's. But Medtronic has been adamant that the GLP-1 drugs won't hurt it over the long haul. There are other potential catalysts. The world's aging population is a clear tailwind for Medtronic, the author notes. Medtronic could also get a boost from using generative artificial intelligence to develop even more effective treatments and equipment. 4. In busy weekend, Disney (DIS) and 20th Century's "Alien: Romulus" won the North American box office with a $45.1M debut, which was well ahead of the expected $20M range. Overseas, the movie grossed an estimated $66.7M for a worldwide tally of $108.2M. The eighth installment in the Alien franchise, which is set between the events of Ridley Scott's 1979 "Alien" and James Cameron's 1986 sequel "Aliens," sports an 82% critics' score on Rotten Tomatoes and received a B+ CinemaScore. "Romulus" was originally expected to go straight to streaming and debut on Disney-owned Hulu. 5. D.R. Horton (DHI) saw a positive mention in this week's edition of Barron's.
CVII

Hot Stocks

20:04 EDT Churchill Capital Corp VII, CorpAcq agree to terminate business combination - Churchill Capital Corp VII, a publicly-traded special purpose acquisition company, and CorpAcq Holdings, a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, announced that they have mutually agreed to terminate their previously announced merger agreement due to IPO market conditions, effective today. "While market conditions are not favorable today for the public listing of CorpAcq through our proposed merger, we continue to believe in the strong fundamentals and growth prospects of the Company," said Michael S. Klein, Chairman and CEO of Churchill VII. "We thank the Churchill and CorpAcq teams for their efforts and for providing this unique opportunity to our investors." In view of the termination of the Merger Agreement, Churchill will not complete an initial business combination by August 17, 2024, being the deadline required by its Amended and Restated Certificate of Incorporation. Churchill intends to dissolve and liquidate the proceeds contained in the trust account in accordance with the provisions of its Certificate of Incorporation. As stated in the Certificate of Incorporation, if Churchill will not complete an initial business combination by August 17, 2024, Churchill will cease all operations except for the purpose of winding up, as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares in consideration of a per share price, payable in cash, equal to the quotient obtained by dividing the aggregate amount then on deposit in the trust account, including interest, by the total number of then outstanding public shares, which redemption will completely extinguish rights of the holders of the public shares, subject to applicable law, and as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, dissolve and liquidate, subject in each case to Churchill's obligations under the General Corporation Law of the State of Delaware, as amended from time to time, to provide for claims of creditors and other requirements of applicable law. The per-share redemption price for the public shares will be approximately $10.84. It is anticipated the last day that Churchill's securities traded on the Nasdaq Global Market was August 16, 2024. Effective as of the Termination Date, the public shares will be deemed cancelled and will represent only the right to receive the Redemption Amount. The Redemption Amount will be payable to the holders of the public shares upon presentation of their respective stock or unit certificates or other delivery of their shares or units to Churchill's transfer agent, Continental Stock Transfer & Trust Company. Beneficial owners of public shares held in "street name," however, will not need to take any action in order to receive the Redemption Amount. There will be no redemption rights or liquidating distributions with respect to Churchill's warrants, which will expire worthless. Churchill's sponsor has waived its redemption rights with respect to the outstanding shares of Class B common stock, par value $0.0001, of Churchill. After the Termination Date, Churchill shall cease all operations except for those required to wind up Churchill's business.